Skip to main content
. Author manuscript; available in PMC: 2024 Aug 7.
Published in final edited form as: Am J Cardiol. 2021 Apr 20;149:1–8. doi: 10.1016/j.amjcard.2021.03.026

Table 2.

The association of retinopathy and incident CAC among those with zero CAC at baseline

Cumulative incidence (%; n at risk) Model A*, relative incident ratio (95% CI) Model B**, relative incident ratio (95% CI) Model C+, relative incident ratio (95% CI) Model D++, relative incident ratio (95% CI)

DM RP absent 42% (255) 1.00 1.00 1.00 1.00
RP present 55% (91) 1.4 (1.1,1.7) 1.3 (1,1.7) 1.2 (0.9,1.5) 1.2 (0.91,1.59)
Non-DM RP absent 32% (24) 1.0 1.0 1.00 1.00
RP present 37% (177) 1.1 (0.9,1.4) 1.1 (0.91,1.32) 1.1 (0.9,1.3) 1.09 (0.9,1.31)
Interaction between retinopathy and DM p value - 0.1466 0.1711 0.6348 0.6392

ABI = ankle brachial index; BMI = body mass index; CAC = coronary artery calcification; CRAE = central retinal arteriolar equivalent; CRP = C-reactive protein; CRVE = central retinal venular equivalent; DM = diabetes mellitus; HbA1c = hemoglobin A1c HDL = high density lipoprotein cholesterol; Log = logarithm; MI = myocardial infarction; RP = retinopathy; SBP = systolic blood pressure.

*

Adjusted for age, gender, race, and follow up time.

**

Adjusted for variables in model a plus cardiovascular risk factors including total cholesterol, HDL-C, log of triglycerides, lipid-lowering medications, SBP, anti-hypertension medications, smoking status and cigarette pack-years.

+

Adjusted for variables in model B plus and BMI, log of CRP, Fibrinogen, log of HbA1C, log of creatinine, glucose, albuminuria, ABI, use of insulin or oral hypoglycemics and family history of MI.

++

Adjusted for variables in model C and CRAE and CRVE.